Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02119065

Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

PET/CT-Derived Hepatopulmonary Shunt Fraction Following Yttrium-90 Radioembolization

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
6 (actual)
Sponsor
University of Cincinnati · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot clinical trial studies positron emission tomography (PET)/computed tomography (CT) in finding beads after Yttrium-90 bead therapy in patients with primary liver cancer or cancer that has spread to the liver (metastatic) that can not be removed by surgery. Imaging procedures, such as PET/CT after Yttrium-90 bead therapy, may help see if the beads are present in the lung and compare the results with the pre-therapy imaging.

Detailed description

PRIMARY OBJECTIVES: I. To estimate the absolute difference in post-therapy Yttrium-90 microsphere hepatopulmonary shunt fraction and the pre-therapy Technetium-99m macroaggregated albumin hepatopulmonary shunt fraction in patients with unresectable primary hepatic malignancy and hepatic metastatic disease. SECONDARY OBJECTIVES: I. To quantify and compare the pre-therapy Technetium-99m macroaggregated albumin particle sizes and post-therapy Yttrium-90 microsphere sizes. OUTLINE: Patients receive routine pre-therapy Technetium-99m macroaggregated albumin. Patients then undergo routine radioembolization with Yttrium-90 microspheres. Within 36 hours after radioembolization, patients undergo PET/CT imaging. Available imaging, clinical, interventional and surgical follow-up data for 2 years after completion of enrollment in the study will be obtained.

Conditions

Interventions

TypeNameDescription
PROCEDUREpositron emission tomographyUndergo PET/CT scan
PROCEDUREcomputed tomographyUndergo PET/CT scan

Timeline

Start date
2014-01-30
Primary completion
2015-07-01
Completion
2026-12-31
First posted
2014-04-21
Last updated
2025-04-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02119065. Inclusion in this directory is not an endorsement.